The interests of neuroscientists and people with Parkinson’s (PwP) are inextricably linked in a symbiotic relationship. Increasingly, funding agencies are unwilling to grant research funds without evidence of PPI involvement. Clinicians readily admit that they gain insights and ideas for future research from their patients; we are then needed as trial participants. Yet when it comes to the easy-to-understand sharing of trial results, PwP are often excluded, the language of journals being mystifying to a non-scientist. Explaining the significance of [...]